http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1247306-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be99925f7e18d5e10b5fc920373c8734
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-26
filingDate 1969-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1971-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1247306-A
titleOfInvention Heterocyclic derivatives of glyoxylic acid, process for their preparation and therapeutical composition containing same
abstract 1,247,306. Isoquinoline and 3-benzazepin compounds from glyoxylic acid. LABORATOIRES HOUDE. 20 Aug., 1969 [2 Sept., 1968], No. 41485/69. Heading C2C. The invention comprises compounds of formula wherein R and R<SP>1</SP> are each H or C 1-5 alkyl and R<SP>11</SP> is H or OH, and a method of making them by reacting 1 mole of with 1 mole of (HO) 2 CHCO 2 R<SP>1</SP>. The isoquinaldic acid esters may be hydrolysed (e.g. with NaOH) to the acids, and the reverse may be effected using e.g. R<SP>1</SP>OH + HC1; the acid where R = H may be methylated with formic acid + formalin. Cis and trans forms of the acids are prepared. Therapeutic compositions for oral and rectal administration comprise compounds of the above formulĀµ, which have anti-tussive activity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8546378-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8946207-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8299241-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8802845-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8153621-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9365521-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8822727-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8367657-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9770455-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8404675-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10226471-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463676-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8501935-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8999970-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8168782-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7704993-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8952197-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9102627-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9169213-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9045431-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9248133-B2
priorityDate 1968-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407559142
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409092530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421930110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19769442

Total number of triples: 45.